Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | est un(e) (attribut) | Meningococcus vaccine (product) | false | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a pour principe actif (attribut) | Meningococcus vaccine (substance) | false | Inferred relationship | Some | 1 | |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of Neisseria meningitidis serogroup B outer membrane vesicle (substance) | true | Inferred relationship | Some | 1 | |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | Count of active ingredient | quatre | false | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a pour principe actif (attribut) | Neisseria meningitidis serogroup B recombinant NHBA protein antigen | true | Inferred relationship | Some | 2 | |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | est un(e) (attribut) | vaccin contenant seulement antigène du méningocoque du sérogroupe B (produit médicinal) | true | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | Has supplier | Novartis Vaccines and Diagnostics Inc. (supplier) | true | Inferred relationship | Some | ||
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding subfamily B protein (substance) | true | Inferred relationship | Some | 4 | |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein (substance) | true | Inferred relationship | Some | 3 | |
| BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR